TP53 and cancer: In addition, PRIMA-1MET, together with cisplatin/carboplatin/doxorubicin/gemcitabine, exerted a synergistic cytotoxic effect in OC cells [160] that was also observed in primary cancer cells isolated from HGSC OC patients with missense TP53 mutations [160,161].